more_reports

DMT Study Set To Explore Breakthrough Potential in Stroke Recovery

  ()
Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) subsidiary Algernon NeuroScience has appointed Dr. Sandor Nardai as Principal Investigator for its upcoming Phase 2a DMT stroke study. Find out how this trial could reshape stroke recovery research.
Tags: Biotechnology / Pharmaceuticals

Healthcare Tech Co. To Acquire Digital Health Platform

  ()
This will expand its ecosystem of AI-powered products. Read on to learn more about its offerings and rapidly growing sector.
Tags: Healthcare Services

New Strategic Moves Aim To Accelerate Growth in AI Healthcare

  ()
Light AI Inc. (ALGO:CBOE) announces major marketing campaigns, advisory board appointments, and a key regulatory partnership to drive growth. Discover how these strategic moves could shape the future of AI healthcare.
Tags: Healthcare ServicesTechnology

Kentucky Medical Co. Has Strong Operating Fundamentals

Research Report
  ()
Quipt Home Medical Corp. (QIPT:NASDAQ; QIPT:TSX.V) received a lowered price target but a Buy rating from a Leede Financial Inc. research note.
Tags: Healthcare ServicesMedical Devices

AI Stock in an Uptrend That Is Likely To Continue

Contributed Opinion
  ()
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy.
Tags: Medical DevicesLife Sciences Tools & Diagnostics

Biotech Requests OK to Assess Device in Second Indication

Research Report
  ()
The company behind this possible "pipeline in a device" wants to evaluate it now in thyroid disease after having begun with trials in type 1 diabetes, noted an H.C. Wainwright & Co. report.
Tags: Medical Devices

Healthcare Pioneer Expands Revolutionary Treatment Platform

  ()
Leading regenerative medicine company Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) says it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its Cell Pouch technology. One analyst says it is the "most advanced encapsulation device in development."
Tags: Biotechnology / PharmaceuticalsMedical Devices

Biotherapeutic Co. Offers Potential Curative Alternative For Thyroid Disease

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) recently filed a new IND for Cell Pouch in thyroid disease. Read on to see what rating and target price Leede Financial Inc. gave this company.
Tags: Biotechnology / Pharmaceuticals

Washington D.C. Pharma Co. Receives FDA Acceptance

Research Report
  ()
Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) recently received FDA acceptance of its request for a hearing regarding its tradipitant New Drug Application, reported an H.C. Wainwright & Co. analyst.
Tags: Biotechnology / Pharmaceuticals

Biotech's Target Price 183.757% Higher Than Current

Research Report
  ()
Read on to see why D. Boral Capital analyst Jason Kolbert gave IMUNON Inc. (IMNM:NASDAQ) a high target price.
Tags: Biotechnology / Pharmaceuticals

AI Infrastructure Push: US$500 Billion Investment Accelerates Drug Discovery

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) highlights the transformative potential of the US$500 billion Stargate Initiative, set to revolutionize AI-driven drug discovery. Learn how this landmark investment could redefine oncology breakthroughs.
Tags: TechnologyBiotechnology / Pharmaceuticals

Biopharma Shares Multiple 2025 Catalysts

Research Report
  ()
Innate Pharma SA's (IPHA:NASDAQ; IPH:Paris) long-term corporate strategy led to it recieving a Buy rating from H.C. Wainwright & Co.
Tags: Biotechnology / Pharmaceuticals

Tech Innovator Achieves Breakthrough Multi-Market Success

  ()
Clean technology company BioLargo Inc. (BLGO:OTCQX) announces it had a "widely successful" and "transformative" 2024 and is looking forward to more revenue growth in 2025. Read why one expert thinks investors should be doubling down on the stock.
Tags: Life Sciences Tools & DiagnosticsTechnologyMedical Devices

Advanced AI Solutions Deliver Hope for CNS Cancer Treatment

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) has identified AI-designed drug candidates targeting advanced cancer treatments with CNS penetration. Read more about how this breakthrough could redefine oncology innovation.
Tags: Biotechnology / Pharmaceuticals

AI-Driven Discovery Unveils Cancer Therapy Breakthrough, Exceeding Projections

  ()
Rakovina Therapeutics Inc. (RKV:TSX.V) has synthesized groundbreaking AI-designed drug candidates targeting critical cancer treatments. Discover how these innovations could reshape oncology research.
Tags: Biotechnology / Pharmaceuticals

Pharma Innovator Reveals Groundbreaking Diabetes Treatment

Research Report
  ()
Biomea Fusion Inc.'s (BMEA:NASDAQ) drug could capture a significant share of the diabetes market, given the large target population globally, D. Boral Capital Analyst Jason Kolbert writes in an updated research note. Read why his target price is nearly a nearly 3,000% increase per share.
Tags: Biotechnology / Pharmaceuticals

Streetwise Reader Icon Streetwise Key Charts
Pharma Biotech & Life Sci

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Biotech Advances Breakthrough Cancer Treatment Results

Research Report
  ()
Sensei Biotherapeutics Inc. (SNSE:NASDAQ) is "well-positioned" to provide a clinical update on its drug targeting advanced solid tumors, Solnerstotug, in 2Q 2025, Oppenehimer & Co. Analyst Francois Brisebois writes in an updated research note.
Tags: Biotechnology / Pharmaceuticals

Should You Double Down on This Story Stock?

Contributed Opinion
  ()
Chris Temple of The National Investor explains why he believes you might want to double down on BioLargo Inc. (BLGO:OTCQX).
Tags: Medical DevicesHealthcare Services

AI Company Unlocks Breakthrough Medical Diagnostics Platform

  ()
One company being listed on Cboe Canada starting January 8 is using AI and smartphones to help patients get quick and accurate diagnosis of their sore throats, helping to battle microbial resistance that threatens the effectiveness of antibiotics worldwide.
Tags: Life Sciences Tools & DiagnosticsMedical Devices

Revenue Surge and Breakthrough Margins Fuel Growth in Critical Care Tech

  ()
CytoSorbents Corp. (CTSO:NASDAQ) reported a 22%-25% revenue jump in Q4, driven by strong performance and expanding global adoption of its flagship product. Read how regulatory breakthroughs in 2025 could redefine the company's market presence.
Tags: Biotechnology / Pharmaceuticals

Pharma Innovator Unlocks Multi-Disease Treatment Potential

Research Report
  ()
Quince Therapeutics Inc. is "positioned for a transformative year" in 2025 with a solid cash position of US$47.8 million as of the third quarter of 2024. Find out why one analyst gives the stock a Buy rating.
Tags: Biotechnology / Pharmaceuticals